
    
      PROTOCOL OUTLINE: Patients receive cyclophosphamide IV on days 1-4 and filgrastim (G-CSF)
      beginning on day 10 and continuing until blood counts recover.

      Patients are followed monthly for 6 months, every 2 months for 6 months, every 4 months for a
      year, and then annually thereafter.
    
  